List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 328 studies with search of: botulinum toxin
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Radial Diffusion of the Botulinum Toxin Type A (Botox®): Electromyographic Evaluation of the Frontal Muscle
Condition: Wrinkles
Intervention: Drug: Botulinum Toxin Type-A (day 0)
2 Completed
Has Results 		Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A
Condition: Wrinkles in Frontal Area
Interventions: Drug: Botulinum Toxin Type A (Dysport®);   Drug: Botulinum Toxin Type A/Botox®;   Drug: Botulinum Toxin Type A/Dysport®
3 Active, not recruiting Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone
Condition: Forehead/Glabellar Rhytid Complexes
Interventions: Procedure: Combination Botulinum Toxin A and Hyaluronic Acid;   Procedure: Botulinum Toxin A
4 Completed Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A from laboratory Lanzhou;   Drug: Botulinum toxin type A from laboratory Allergan
5 Unknown † Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain
Condition: Chronic Low Back Pain
Interventions: Drug: Botulinum Toxin A / Placebo;   Drug: Botulinum Toxin A / Botulinum Toxin A;   Drug: Placebo / Botulinum Toxin A;   Drug: Placebo / Placebo
6 Terminated
Has Results 		Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Condition: Overactive Bladder
Interventions: Biological: Normal saline (Placebo); botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (50U); botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (100U); botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (200U)
7 Recruiting Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A 200U;   Biological: botulinum toxin Type A 300U;   Biological: placebo; botulinum Toxin Type A 200U;   Biological: Placebo; botulinum toxin Type A 300U
8 Completed
Has Results 		Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (300U);   Other: Normal saline (Placebo); botulinum toxin Type A (200U);   Other: Normal saline (Placebo); botulinum toxin Type A (300U)
9 Completed
Has Results 		Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (300U);   Other: Normal Saline (Placebo); botulinum toxin Type A (200U);   Other: Normal Saline (Placebo); botulinum toxin Type A (300U)
10 Unknown † Botulinum Toxin Injection for Treatment of Vaginismus
Condition: Vaginismus
Interventions: Drug: botulinum toxin;   Drug: botulinum toxin A
11 Completed Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
Conditions: Facial Rhytides;   Crow's Feet Lines;   Glabellar Lines
Interventions: Other: botulinum toxin type A and Normal Saline (placebo);   Biological: botulinum toxin type A;   Drug: Normal Saline
12 Completed Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A;   Biological: Placebo/botulinum toxin Type A
13 Completed Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A;   Biological: Placebo/botulinum toxin Type A
14 Active, not recruiting Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines
Conditions: Facial Rhytides;   Glabellar Frown Lines
Interventions: Biological: botulinum toxin Type A (30 Units);   Biological: botulinum toxin Type A (40 Units);   Drug: Normal Saline
15 Recruiting Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
Condition: Refractory Migraine
Intervention: Drug: Botulinum toxin A
16 Recruiting Efficacy of Botulinum Toxin Type A in Patients With Bladder Pain Syndrome/Intersticial Cystitis and Hunners' Lesions
Condition: Interstitial Cystitis
Interventions: Procedure: intratrigonal injection of botulinum toxin;   Procedure: cystoscopy
17 Completed Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows
Conditions: Glabellar Rhytides;   Frown Lines Between the Eyebrows
Interventions: Drug: Mentor Purified Toxin Botulinum Toxin Type A;   Drug: Preservative-free Saline
18 Unknown † The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
19 Active, not recruiting Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies
Condition: Normal, Healthy Volunteers
Interventions: Drug: Botulinum Toxin, Type A;   Drug: Saline
20 Recruiting Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora
Condition: Epiphora
Intervention: Drug: Botulinum Toxin Type A

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services